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Abstract Background: Nitric oxide
(NO) plays an important physiologi-
cal role in inter-cellular communica-
tion, but when produced in excess it
can become toxic. Our goal was to
evaluate possible involvement of NO
in the development of retinopathy in
diabetic rats. Methods: Diabetes was
induced in male albino rats by intra-
venous injection of streptozotocin.
Some of the normal and diabetic rats
were raised with added L-arginine 
to increase in vivo NO synthesis, 
or with added L-NAME to inhibit
the rate of in vivo NO synthesis.
NADPH diaphorase histochemistry
was conducted on retinal whole
mounts and transverse sections at
different time intervals after induc-
tion of diabetes. The electroretino-
gram (ERG) was recorded to assess
retinal function. Results: After
6 weeks of diabetes, NADPH diaph-
orase amacrine cells in the diabetic
retinas appeared abnormal in their
morphology and the degree of stain-
ing was decreased in their processes.
In contrast, NADPH diaphorase ac-
tivity was augmented in Müller cells.
Supplementing the rats’ diet with 
L-arginine for 10 weeks slightly re-
duced NADPH diaphorase activity in
amacrine cell in normal rats but had
no effect on the diabetic rats. Adding
L-NAME for 10 weeks did not alter
NADPH diaphorase histochemistry
in either normal or diabetic rats. The
ERG responses were reduced by 
L-arginine supplementation in nor-
mal and diabetic rats, and were un-
affected by adding L-NAME to the
drinking water. Conclusions: Our
findings are consistent with the hy-
pothesis that high glucose levels 
are deleterious to the rat retina and
that excessive synthesis of NO may
contribute to the development of 
diabetic retinopathy.
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NADPH diaphorase activity in the rat retina
during the early stages of experimental 
diabetes
Introduction
Nitric oxide (NO) has been shown to play a major physi-
ological role in inter-cellular communication [5, 35, 45].
It is produced from L-arginine by the enzyme nitric ox-
ide synthase (NOS) [4] and acts upon the cytosolic form
of guanylate cyclase in the target cells [26, 28]. Three
isoforms of NOS have been identified [33, 35]. The en-
dothelial (eNOS) and neuronal forms (nNOS) are consti-
tutive enzymes that produce physiological levels of NO
for normal functioning of vascular beds and neuronal tis-
sues. The inducible form of NOS (iNOS) produces NO
at high rates that can become toxic to living tissue.
One of the primary functions of NO is to control the
rate of blood flow via its effects on the vascular smooth
muscle [33, 37]; therefore, the NO system has been the
focus of numerous studies concerning vascular-related
complications of diabetes mellitus. Conflicting findings
on NO involvement in animal models of diabetes have
been reported over the years. Several studies reported
that endothelium-dependent relaxation of aortic rings or
isolated mesenteric arteries was reduced [13, 27, 36, 38].
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This was attributed to a reduction in NO synthesis from
L-arginine [38] or to a reduced response of the vascular
smooth muscle to NO [13]. In another study, the endo-
thelium-dependent vascular relaxation was impaired,
whereas the response to exogenous application of NO
was normal indicating normal responsiveness of the vas-
cular smooth muscle to NO but impaired NO synthesis
[50]. In contrast to the above-mentioned reports, the en-
dothelial cells of the mesenteric arteries in rats with pro-
longed diabetes were found to release normal levels of
vasodilator substances, and the arteries were found to re-
spond normally to exogenous application of NO [17].
Human studies also yielded conflicting results; some
showed impaired endothelium-derived NO activity with
normal response to exogenous NO [49], whereas others
reported that both tests for NO-vascular interaction were
reduced [6, 51] or normal [2, 44].
The involvement of NO in the development of diabet-
ic retinopathy has been investigated in several studies.
Patients with proliferative diabetic retinopathy were
characterized by elevated levels of NO in the vitreous
[53]. Ocular hemodynamic reactivity to inhibition of NO
synthesis was impaired in patients with long-standing
IDDM compared with healthy subjects [41]. From these
and other studies, it is apparent that the exact role of NO
in the development of diabetic complications is not yet
clear.
We have recently shown that the functional integrity
of the rat retina in streptozotocin (STZ)-induced diabetes
is reduced as early as 2 weeks after induction of diabetes
[31]. The present study was designed to test the possible
involvement of the NO system in the early stages of reti-
nopathy in diabetic rats. Histochemical and immuno-
cytochemical studies of the normal rat retina demonstrat-
ed the presence of NOS in amacrine cells and in few dis-
placed amacrine cells [12, 14, 40, 52, 54]. The endotheli-
al form of NOS (eNOS) was also demonstrated in rat
Müller cells and endothelial cells [23]. Herein we ap-
plied NADPH diaphorase histochemistry to retinal whole
mounts and transverse retinal sections of rats at different
time intervals after induction of diabetes. The effects of
adding L-arginine or L-NAME to the drinking water on
retinal function (ERG responses) and NADPH diapho-
rase activity was studied in normal and diabetic rats.
Materials and methods
Animals
Male Sprague-Dawley rats, weighing approximately 200 g, were
used in this study. Sixty rats were studied: 24 in the normal group
and 36 in the diabetic group. Diabetes was induced as described
previously [31] by intravenous injection (caudal vein) of strepto-
zotocin (STZ; Sigma, St. Louis, Mo.). Diabetes was confirmed by
fasting hyperglycemia in excess of 350 mg/dl. Normal rats,
matched in age and gender to the diabetic rats, were studied in
parallel to the diabetic rats.
The diabetic and normal rats were housed in the same room
and were maintained on a standard diet and water ad libitum, un-
der 14/10 h light/dark cycle. In order to increase in vivo synthesis
of nitric oxide, L-arginine (1 g/l) was added to the drinking water
as a substrate for NO synthesis [36]. Nω-nitro-L-arginine methyl
ester (L-NAME; 0.1 g/l) was used as a competitive inhibitor of
NO synthesis [39] to reduce in vivo synthesis of NO.
All experimental procedures conformed to the ARVO recom-
mendations for the use of laboratory animals and to institutional
guidelines.
Electroretinogram
Rats were anesthetized by intra-muscular injection of a solution
containing ketamine hydrochloride solution (10 mg/ml), acepro-
mazine maleate solution (10%), and xylazine solution (2%) in the
following volume proportions: 1.0:0.2:0.3, respectively. The dose
used (0.5 ml/kg body weight) was sufficient to prevent pain as
judged from tail reflex, yet it was not too deep to affect the ERG
responses. The pupils were fully dilated with cyclopentolate hy-
drochloride 1%. Topical anesthesia (benoxinate HCl 0.4%) was
administered before ERG recordings.
Prior to the ERG recording session, rats were maintained in
complete darkness overnight and prepared for the recordings un-
der dim red illumination. The ERG responses were recorded as de-
scribed previously [31], from both eyes with corneal electrodes
(Medical Workshop, Groningen, Holland). The reference and
ground electrodes were made of surgical needles and were insert-
ed into the pinnae. The signals were amplified (×10,000) and fil-
tered (0.3–300 Hz) by differential preamplifiers (Grass, West War-
wick, Rhode Island), then digitized by a personal computer
equipped with a data acquisition board (Scientific Solutions, So-
lon, Ohio). To improve signal/noise ratio, 6 ERG responses, which
were elicited at 10-s intervals by identical light stimuli, were aver-
aged on-line. Light stimuli were obtained from a Ganzfeld light
source (LKC Technologies, Gaithersburg, Md.) with maximum,
unattenuated stimulus intensity of 5.76 cd-s/m2. The ERG re-
sponses were elicited by white light stimuli covering intensity
range of more than 4 log units using neutral density filters.
The ERG analysis consisted of amplitude and implicit time
measurements. The implicit time of the b-wave was measured
from stimulus onset to the peak of the b-wave. The amplitude of
the a-wave was measured from the baseline to the trough of the a-
wave, and the amplitude of the b-wave was determined from the
trough of the a-wave to the peak of the b-wave. To assess retinal
function, the relationships between the amplitudes of the dark-
adapted a- and b-waves and stimulus intensity were fitted to a hy-
perbolic-type relationship [24]:
(1)
In this equation, V and Vmax are respectively the amplitudes of
the ERG wave elicited by a stimulus of intensity I and by a stimu-
lus of super-saturating intensity. The parameter σ is the semi-satu-
ration constant and denotes the stimulus intensity eliciting a re-
sponse of half-maximal amplitude.
NADPH diaphorase histochemistry
NADPH diaphorase histochemistry is a common method for iden-
tifying all three isoforms of NOS [3, 4, 15, 25, 42]. Since NADPH
diaphorase activity reflects the ability of NOS to convert the dye
nitro blue tetrazolium into an insoluble formazan salt, this method
determines the amount of active NOS that is present immediately
prior to fixation and not the total amount of NOS [5, 34]. This ex-
plains some discrepancies between immunocytochemistry and
NADPH diaphorase histochemistry because a large amount of
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non-active NOS will lead to intense immunoreactivity and faint
NADPH diaphorase activity, and vice versa, a small amount of ac-
tive NOS will cause faint immunoreactivity and intense NADPH
diaphorase activity [34]. Thus, the disadvantage of NADPH diaph-
orase histochemistry is its lack of specificity of NOS isoforms, but
its advantage is its ability to determine the degree to which NOS
molecules are activated at the time of tissue fixation.
NADPH diaphorase histochemistry was applied, as described
previously [54], to retinal whole mounts and to transverse retinal
sections. Rats were anesthetized with sodium pentobarbital
(40 mg/kg body weight) and the eyes were enucleated. Then, the
rats were killed with an overdose (80 mg/kg body weight) of sodi-
um pentobarbital. The eye was fixed for 10 min in 0.1 M phos-
phate buffer (pH=7.4) containing 4% paraformaldehyde. The ante-
rior portion of the eye was dissected away and the eyecup was left
for additional 10 min of fixation. The eyecup was incubated at
37°C for 135 min in the reaction solution (0.2% Triton X-100,
0.5 mM nitro blue tetrazolium, 1 mM NADPH, 9 mM L-NAME
and 50 µm CaCl2 in 0.1 M Tris-Cl, pH=7.4), and then, the eyecup
was rinsed twice in 0.1 M Tris-Cl buffer (pH=7.4).
For the whole-mount preparation, the retina was isolated from
the eyecup using a fine spatula and mounted on a slide with Immu-
mount medium (Thermo Shandon, Pittsburgh, Pa.). For transverse
sections, the eyecup was treated as described previously and then
transferred to Karnovsky’s fixation medium (2% paraformaldehyde
and 2.5% glutaraldehyde in 0.1 M phosphate buffer) for 24 h. The
eyecup was embedded in JB-4 resin (Polysciences, Warrington,
Pa.), and cut with a microtome (Reichert-Jung, Nussloch, Germa-
ny) into sections of 10-µm thickness, and placed on slides.
Results
Normal diet
Diabetic rats were characterized by hyperglycemia that
increased within the first few days after injection of
streptozotocin (STZ) and remained constant throughout
the follow-up period (30 weeks). In the normal rats,
blood glucose was around 70 mg/dl and in the diabetic
rats above 400 mg/dl [31]. The diabetic rats were also
characterized by a slow gradual loss of weight compared
with the normal rats that gained weight. Before induction
of diabetes, all the rats were approximately 200 g in
body weight, whereas towards the termination of the fol-
low-up period (30 weeks), the normal rats weighed ap-
proximately 600 g and the diabetic rats approximately
130 g [31].
The enzyme NOS was found mainly in rat amacrine
cells [12, 14, 40, 52, 54] that are best visualized in 
the retinal whole-mount preparation. Figure 1 shows
NADPH diaphorase histochemistry of retinal whole
mounts from 2 normal (Fig. 1A, C) and 2 diabetic
(Fig. 1B, D) rats that were killed 6 weeks (Fig. 1A, B) or
25 weeks (Fig. 1C, D) after induction of diabetes. The
NADPH diaphorase active amacrine cells are easily
identified in all four micrographs (arrows); however,
their shape and the pattern of staining clearly differ be-
tween the normal and diabetic retinas. The NADPH di-
aphorase amacrine cells in the normal retina are charac-
terized by densely stained cell bodies and long stained
processes (Fig. 1A, C). All retinas from normal rats, that
were treated for NADPH diaphorase histochemistry
(n=12), and studied at different time intervals of follow-
up (up to 25 weeks), exhibited similar pattern of
NADPH diaphorase activity in amacrine cells indicating
no age-dependent changes. In contrast, NADPH diapho-
rase amacrine cells in the diabetic retinas (Fig. 1B, D)
appeared to be smaller in size, were spherical in shape,
749
Fig. 1A–D NADPH diapho-
rase histochemistry of retinal
whole mounts from two normal
(A, C) and two diabetic (B, D)
rats. The rats were studied
6 weeks (A, B) and 25 weeks
(C, D) after induction of diabe-
tes. NADPH diaphorase ama-
crine cells are seen in all four
micrographs (arrows). They are
strongly stained and contain
long stained processes in the
normal retinas (A, C). In the
diabetic retina, the amacrine
cells are characterized by small
cell bodies of spherical shape
and they lack stained processes
(B, D). Calibration bar for all
micrographs: 25 µm
and lacked stained processes. All retinas from diabetic
rats, that underwent NADPH diaphorase histochemistry
(n=24), exhibited the same changes in amacrine cells as
shown in Fig. 1B, D), indicating early onset of pathology
(6 weeks), and no further deterioration within 25 weeks
of follow-up. Another difference between diabetic and
normal rats was noted in the background appearance of
the retinal whole mounts. We suspect that this difference
arises from differences in tissue consistency (water con-
tent), due to the high (>350 mg/dl) glucose levels.
Transverse retinal sections were used to observe dia-
betic-induced changes in NADPH diaphorase activity of
deeper retina structures. Transverse sections of 2 normal
(A and C) and 2 diabetic (B and D) rats that were pre-
pared for NADPH diaphorase histochemistry 7 weeks (A
and B) and 14 weeks (C and D) after onset of diabetes
are shown in Fig. 2. The cells that are most easily identi-
fied as NADPH diaphorase positive are the amacrine
cells that are seen in the proximal border of the inner nu-
clear layer of all four micrographs (arrows in Fig. 2).
Other structures in the INL that are less prominently
stained may be small-caliber blood vessels [54]. The ma-
jor difference between the normal and diabetic retina is
seen in the Müller cells. In the 7-week diabetic retina,
the endfeet of the Müller cells (arrowheads in Fig. 2B)
are stained more than those in the retina of the normal rat
(arrowheads in Fig. 2A). This difference between the di-
abetic and normal retinas seems to increase with period
of diabetes. The transverse retinal section from the 14-
week diabetic rat (Fig. 2D) shows intense NADPH di-
aphorase activity in the endfeet of the Müller cells (ar-
rowheads) that extends throughout the entire length of
the Müller cells. In the normal retina, only faint NADPH
diaphorase activity is seen, confined to the endfeet of the
Müller cells (arrowheads in Fig. 2C).
The NADPH diaphorase activity was also observed
along the walls of the blood vessels (both arteries and
veins), reflecting the presence of eNOS in endothelial
cells [23]; therefore, we could use the retinal whole
mounts that had been treated for NADPH diaphorase his-
tochemistry, to assess pathological changes in the retinal
vasculature. In all the rats that were studied at periods of
diabetes shorter than 20 weeks, the blood vessels of the
diabetic retina appeared similar to those of the normal
retina at the light microscopic level (not shown here). In
rats suffering from longer periods of diabetes, differ-
ences became evident. In Fig. 3, NADPH diaphorase of
retinal whole mount from a rat suffering from diabetes
for 25 weeks (Fig. 3B) is compared with a normal rat ret-
ina (Fig. 3A). These micrographs were taken from simi-
lar retinal regions. The vascular tree appears very dis-
tinct in the normal retina and exhibits intense staining
(Fig. 3A), whereas the blood vessels in the diabetic reti-
na appear thinner, less robust, and are stained more faint-
ly for NADPH diaphorase (Fig. 3B).
Nitric oxide diet
Several studies have suggested that manipulation of the
retinal level of NO in diabetic animals can prevent, or at
750
Fig. 2A–D NADPH diaphorase activity in transverse retinal sec-
tions of two normal (A, C) and two diabetic (B, D) rats that were
studied 7 weeks (A, B) or 14 weeks (C, D) after onset of diabetes.
Stained amacrine cells can be seen in the proximal border of the
INL in all four micrographs (arrows). In the 7-week diabetic reti-
na, strong NADPH diaphorase staining is observed in the endfeet
of Müller cells (arrowheads in B). With time of diabetes, NADPH
diaphorase activity expanded to the entire length of the Müller
cells D. In contrast, the Müller cells in the normal retina of any
age are labeled to a lesser extent and NADPH diaphorase staining
is confined to their endfeet (arrowheads in A and C). Marked reti-
nal layers: outer segments of photoreceptors (PH); outer nuclear
layer (ONL); inner nuclear layer (INL); and ganglion cell layer
(GCL). Calibration bar for all micrographs: 50 µm
Fig. 3A, B The retinal vascular bed, as seen by NADPH diapho-
rase histochemistry, of normal A and diabetic B rats which were
studied 25 weeks after induction of diabetes. NADPH diaphorase
activity is clearly visible in the walls of the blood vessels in both
retinas. The blood vessels appear more densely stained in the nor-
mal retina (A) compared with the diabetic retina (B). Calibration
bar: 50 µm
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least slow down, the development of retinopathy; how-
ever, there is no agreement as to whether NO synthesis
should be reduced or augmented. Some authors have hy-
pothesized that reduced NO production and/or reduced
responsiveness to NO occurred in diabetes, and there-
fore, the level of NO should be augmented, whereas oth-
ers have assumed that excess of NO synthesis in the dia-
betic retina was deleterious. Thus, treatment of diabetic
rats with a nitrovasodilator (adding NO) was found to
prevent the reduction in nerve conduction velocity and in
blood flow [7]. In contrast, treating diabetic rats with
guanidine compounds, that inhibit NO synthesis by
iNOS, prevented the elevation in the permeability of vas-
cular vessels to albumin [47], and the development of di-
abetic retinopathy [20].
To test these possibilities, we raised normal rats and
diabetic rats with added L-arginine to stimulate in vivo
NO synthesis [36], or L-NAME, to inhibit in vivo NO
synthesis [39], to the drinking water. These manipula-
tions were expected to affect the blood pressure, but it
was not monitored here. Instead, we assumed that the ef-
fects were similar in diabetic and normal rats and com-
pared the two groups that were treated similarly. The
ERG responses were measured at different time intervals
to assess retinal function, and after 10 weeks of follow-
up, the rats were killed and their retinas were prepared
for NADPH diaphorase histochemistry. Figure 4 shows
ERG responses from three normal rats that were main-
tained for 8 weeks on normal, L-arginine, or L-NAME
diet. The ERG responses of the rat receiving L-arginine
in the drinking water were smaller in amplitude com-
pared with those of the rat on normal drinking water and
those of the rat with L-NAME added to the water. The
diabetic rats exhibited similar trend of diet effect on the
ERG responses; reduction by adding L-arginine to the
drinking water (not shown here).
The ERG responses were recorded from 12 normal
and 12 diabetic rats that were raised for 8–10 weeks with
water containing either 0.1% L-arginine or 0.01% L-
NAME (6 rats in each group). The response–intensity
curves for the a-wave and b-wave were constructed from
these ERG responses and were fitted to Eq. (1) in order
to derive the amplitude of the maximum response
(Vmax) and the semi-saturation constant (σ) [24]. The
average (±SD) values of these ERG parameters and of
blood glucose for these groups of rats are summarized in
Table 1 and compared with similar data from diabetic
and normal rats that were raised with regular tap water.
Statistical analysis was conducted by Student’s t test. In
normal rats, supplementing the drinking water with L-ar-
ginine induced a slight, but not significant, increase in
the semi-saturation constants of the ERG a-wave and b-
wave, but significantly (p<0.01) reduced their maximum
amplitudes (Table 1). This indicates a reduction in the
functional integrity of the distal rat retina. Adding L-
NAME to the drinking water exerted no effect on the
dark-adapted ERG responses of normal rats (Table 1).
The NO diet also affected the level of blood glucose in
normal rats. It was significantly higher in rats maintained
on water with added L-arginine (p<0.01) and in those
kept on L-NAME enriched water (p<0.05). In the diabet-
ic rats, adding L-arginine to the drinking water slightly
reduced (p<0.05) the maximum amplitude of the a- and
b-waves, whereas L-NAME exerted no significant ef-
fects (Table 1). L-arginine or L-NAME did not affect the
levels of blood glucose of the diabetic rats.
Micrographs of retinas from normal rats that were
treated for 10 weeks with L-arginine or L-NAME and
were processed for NADPH diaphorase histochemistry
are shown in Fig. 5. In the retinal whole mounts,
NADPH diaphorase amacrine cells are clearly visible
(arrows in Fig. 5) in the retina of both normal rats that
were raised on L-arginine (A) or L-NAME (B) enriched
diet. The cell bodies of these amacrine cells appear
similar in shape and degree of staining to those found
in normal rats raised under normal conditions (Fig. 1A,
C); however, the NADPH diaphorase amacrine cells in
the retina of the rat raised with L-arginine diet
(Fig. 5A) lack stained processes, like those of diabetic
rats. The NADPH diaphorase activity in Müller cells
was also slightly affected by the type of diet. In the
transverse retinal section of the rat that was raised on
L-arginine diet (Fig. 5C), the endfeet of the Müller
cells were stained more heavily compared with the
transverse sections from normal rats that were raised on
L-NAME diet (Fig. 5D) or normal tap water (Fig. 2A).
Similar NADPH diaphorase histochemistry was seen in
three rats of each experimental group (L-arginine diet




(ERG) responses of three nor-
mal rats that were raised for
8 weeks with a diet containing
normal tap water (first column),
L-arginine (0.1%) water (sec-
ond column), and L-NAME
(0.01%) water (third column).
The ERG responses were re-
corded in the dark-adapted
state using light stimuli of dif-
ferent intensities as denoted to
the left of each row of respons-
es. Each pair of traces repre-
sents the ERG responses of the
left (upper trace) and right
(lower trace) eyes. Calibration
bars: vertical 100 µV, horizon-
tal 100 ms
Table 1 The effects of adding L-arginine or L-NAME to the
drinking water (8–10 weeks) on retinal function and blood glucose
of normal (a) and diabetic (b) rats. Each group contained six rats.
The average±SD of Vmax and σ were calculated by fitting the
ERG response–intensity curves to a hyperbolic function (Eq. 1).
Statistical tests (Student’s t test) were performed between the ex-
perimental groups (L-arginine and L-NAME) and the correspond-
ing regular-water group
Regular water L-arginine (0.1%) L-NAME (0.01%)
(a) Normal rats
a-wave Vmax (µV) 364±63 249±47** 432±143
σ (cd-s/m2) 0.260±0.105 0.351±0.125 0.297±0.092
b-wave Vmax (µV) 757±205 475±113** 762±193
σ (cd-s/m2) 0.0055±0.0029 0.0081±0.0076 0.0041±0.0014
Blood glucose (mg/dl) 69±5 190±37** 146±53*
(b) Diabetic rats
a-wave Vmax (µV) 270±6856 202±62* 276±104
σ (cd-s/m2) 0.312±0.118 0.288±0.098 0.233±0.094
b-wave Vmax (µV) 439±105 297±94* 344±97113
σ (cd-s/m2) 0.0047±0.0022 0.0148±0.0115* 0.0095±0.069
Blood glucose (mg/dl) 448±33 420±72 424±41
*p<0.05, **p<0.01
Fig. 5A–D NADPH diaphorase
histochemistry of retinal whole
mounts (A, B) and transverse
retinal sections (C, D) of four
normal rats that were raised for
8 weeks on a diet containing 
L-arginine (A, C) or L-NAME
(B, D) in the drinking water.
The cell bodies of NADPH di-
aphorase amacrine cells are
similarly stained in both retinal
whole mounts (arrows in A and
B), but those in the L-arginine-
treated rat lack stained process-
es (A). In the transverse sec-
tions, the endfeet of the Müller
cells exhibit more profound
NADPH diaphorase activity in
the retina from the L-arginine
treated rat (arrowheads in C),
compared with the L-NAME-
treated rat (arrowheads in D).
Calibration bar: 25 µm for A
and B, 50 µm for C and D
Fig. 6A–D NADPH diapho-
rase histochemistry of retinal
whole mounts (A, B) and trans-
verse retinal sections (C, D) of
four diabetic rats that were
raised for 8 weeks on a diet
containing L-arginine (A, C) or
L-NAME (B, D) in the drink-
ing water. The NADPH diapho-
rase amacrine cells are similar-
ly stained in both retinal whole
mounts (arrows in A and B). In
the transverse sections, the end-
feet of the Müller cells are in-
tensely stained for NADPH di-
aphorase (arrowheads in C and
D). Calibration bar: 25 µm for
A and B, 50 µm for C and D
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Adding L-arginine or L-NAME to the drinking water
of diabetic rats did not affect the pattern of NADPH di-
aphorase histochemistry as shown in Fig. 6. In the retinal
whole mounts from both rats, NADPH diaphorase ama-
crine cells can be identified (arrows in Fig. 6A, B). The
bodies of the amacrine cells in both retinas appear small-
er in size compared with those in the normal rats
(Fig. 5A, B), and are characterized by abnormal shape
(spherical) and lack stained processes. Also, the trans-
verse sections from the retinas of both diabetic rats ap-
pear similar (Fig. 6C, D). Stained amacrine cells can be
seen in the proximal region of the INL (arrows), whereas
staining in the distal region of the INL probably belong
to small-caliber blood vessels [54]. In both retinas (ar-
rows in Fig. 6C, D), NADPH diaphorase staining in
Müller cells is stronger than in retinas from normal rats
(Fig. 5). Similar results were seen in retinas from three
diabetic rats treated with L-arginine and three diabetic
rats treated with L-NAME, that were prepared for
NADPH diaphorase histochemistry after 10 weeks on
NO diet.
Discussion
The data presented herein clearly show that the pattern of
NADPH diaphorase activity in the rat retina is affected
by diabetes. Assuming that NADPH diaphorase is a
marker for nitric oxide synthase [3, 15, 21, 25], and that
the degree of staining reflects only active NOS molecules
at the time of tissue fixation [5, 34], these observations
indicate significant changes in the NO system of the dia-
betic rat retina. In the normal retina, the neuronal cells
that consistently exhibit NADPH diaphorase activity are
amacrine cells (Fig. 1A, C) in agreement with previous
reports [12, 14, 40, 52, 54]. We also found NADPH di-
aphorase activity in the endfeet of the Müller cells
(Fig. 2A, C), whereas a previous study demonstrated
eNOS immunoreactivity throughout most of the length of
the Müller cells [23]. This difference probably reflects
the different types of measurements. While immunocyto-
chemistry stains all NOS molecules, NADPH diaphorase
stains only active NOS molecules [34]; thus, Müller cells
in the normal rat retina probably contain eNOS but not in
an active form. We also found NADPH diaphorase activi-
ty in the walls of the retinal blood vessels (arterial and
venous parts) (Fig. 3), as reported previously [23], and in
small-caliber vessels deep in the INL [54].
In the diabetic retina, the distribution of NADPH di-
aphorase-positive amacrine cells across the retina did not
differ from that in the normal retina, but the cells differ
from those in the normal retina by their smaller size,
spherical shape, and the lack of stained processes. This
was seen as early as 6 weeks after induction of diabetes
(Fig. 1B) and did not change markedly with time up to
25 weeks of follow-up (Fig. 1D). Similar observation has
been reported previously [39]. This effect of diabetes can
be an indirect consequence of the high glucose level
(>350 mg/dl) that may lead to ketoacidosis and dehydra-
tion. Alternatively, a direct link between high glucose
and cellular function needs to be considered [32]. The
effects of L-arginine-enriched diet on the NADPH diaph-
orase amacrine cells in the normal rat (Fig. 5A) tend to
support the latter alternative. Furthermore, a recent study
showed abnormal photopic ERG responses in healthy
volunteers suffering from high blood glucose levels dur-
ing glucose-loading experiments [16].
In contrast to the reduced NADPH diaphorase activity
in amacrine cells, we found an increase in the activity of
NADPH diaphorase in Müller cells of the diabetic rat
retina (Fig. 2). Since NADPH diaphorase can detect
equally all NOS isoforms, we could not define the type
of NOS that was expressed in the Müller cells of the dia-
betic retina. Based on previous findings, we suggest that
NADPH diaphorase activity in the Müller cells reflects
the inducible isoform of NOS. A recent study of retinas
from diabetic patients showed increased immunoreactiv-
ity for iNOS in cells that were identified as Müller cells
[1]. Furthermore, NO synthesis in the diabetic rat retina
could be significantly reduced by adding iNOS antago-
nist, whereas antagonists for cNOS were considerably
less effective [10].
The induction of iNOS in Müller cells of the diabetic
retina can reflect toxicity of streptozotocin, a possibility
that was not tested directly here. Alternatively, it can re-
flect a response to subnormal rate of NO synthesis due to
loss of NADPH diaphorase amacrine cells. The experi-
ments in which L-NAME or L-arginine were added to
the drinking water of normal and diabetic rats tend to ex-
clude this possibility. Reducing NO synthesis in the nor-
mal retina (adding L-NAME) did not induce NADPH di-
aphorase activity in Müller cells (Fig. 5D), whereas rais-
ing NO synthesis in the diabetic retina (adding L-argi-
nine) did not prevent the increase in NADPH diaphorase
activity in the Müller cells (Fig. 6C). The most likely
possibility attributes the diabetic-induced changes in
NADPH diaphorase in retinal Müller cells to the high
glucose level that can act directly to induce NOS expres-
sion and/or indirectly by increasing the levels of cyto-
kines (e.g., IL-1β). Interleukin-1β was found to induce
the expression of NOS in colonic smooth muscle cells
[30] and to stimulate NO production and uptake of L-ar-
ginine in vascular smooth muscle cells [8, 18]. A stimu-
latory effect of hyperglycemia on nitric oxide synthase
activity was demonstrated in isolated rat and human cells
[43, 46] and on the rate of NO synthesis in an isolated rat
retina [29].
The deleterious effect of hyperglycemia on the rat ret-
ina [31] is emphasized by the subnormal ERG responses
that were recorded from normal rats that were raised on
water with added L-arginine (Fig. 4; Table 1). The levels
of blood glucose in these rats (190±37 mg/dl) were sig-
nificantly (p=0.0002) higher than in rats that were main-
tained on regular tap water (69±5 mg/dl), but lower than
in our diabetic rats (>350 mg/dl). Thus, added L-arginine
caused elevation in blood glucose that was probably suf-
ficient to cause a reduction in retinal function as assessed
from the ERG responses, and slight changes in the
NADPH diaphorase amacrine cells (Fig. 5A, C). The
concentration of plasma glucose also increased in normal
rats raised on L-NAME enriched diet (146±53 mg/dl),
but to a lesser extent compared with the effects of the L-
arginine diet (p=0.015), and was probably insufficient to
affect the ERG responses (Fig. 4) and NADPH diapho-
rase activity (Fig. 5B, D). The exact pathway leading to
elevation of blood glucose due to added L-arginine was
not studied here; however, increased activity of gluco-
neogenesis is one possibility.
The data presented herein and in previous reports sup-
port a role for NO in the development of diabetic reti-
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nopathy. We suggest that in the early stages of diabetes,
before vascular changes become evident, the activity of
cNOS in amacrine cells decreases but induction of iNOS
in Müller cells may lead to an overall increase rate of
NO synthesis. Increased synthesis of NO was found in
diabetic patients with no signs of diabetic retinopathy
[22] and in diabetic rats [10, 29]. The excess production
of NO can strengthen the deleterious effects of hypergly-
cemia and thus, contributes to the development of dia-
betic retinopathy. NO has been shown to contribute to
the breakdown of the blood-retinal barrier [9, 11] and to
the VEGF-induced hyperpermeability of blood vessels
[48]. Elevated levels of NO have been suggested to inter-
act with elevated levels of glutamate to further exacer-
bate the oxidative stress that is induced by diabetes [29].
Furthermore, NO is a reactive radical that by itself can
cause death of retinal neurons [19]; thus, the induction of
iNOS in retinal Müller cells in the early stages of diabe-
tes seems to play a positive feedback role by augmenting
the deleterious effects of hyperglycemia.
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